首页> 外文期刊>细胞研究(英文版) >A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations
【24h】

A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations

机译:通过化学组合诱导成纤维细胞多谱系反分化的分子路线图

获取原文
获取原文并翻译 | 示例
       

摘要

Recent advances have demonstrated the power of small molecules in promoting cellular reprogramming.Yet,the full potential of such chemicals in cell fate manipulation and the underlying mechanisms require further characterization.Through functional screening assays,we find that mouse embryonic fibroblast cells can be induced to trans-differentiate into a wide range of somatic lineages simultaneously by treatment with a combination of four chemicals.Genomic analysis of the process indicates activation of multi-lineage modules and relaxation of epigenetic silencing programs.In addition,we identify Sox2 as an important regulator within the induced network.Single cell analysis uncovers a novel priming state that enables transition from fibroblast cells to diverse somatic lineages.Finally,we demonstrate that modification of the culture system enables directional trans-differentiation towards myocytic,glial or adipocytic lineages.Our study describes a cell fate control system that may be harnessed for regenerative medicine.
机译:最近的进展证明了小分子在促进细胞重编程中的作用。然而,此类化学物质在细胞命运操纵中的全部潜力及其潜在机制尚需进一步表征。通过功能筛选试验,我们发现可以诱导小鼠胚胎成纤维细胞产生通过使用四种化学物质进行处理,可同时分化为多种体细胞谱系。该过程的基因组分析表明,多种谱系模块的激活和表观遗传沉默程序的松弛。此外,我们确定Sox2是其中的重要调控因子单细胞分析揭示了一种新的启动状态,该状态可以使成纤维细胞转变为多种体细胞谱系。可能是危险的细胞命运控制系统用于再生医学。

著录项

  • 来源
    《细胞研究(英文版)》 |2017年第3期|386-401|共16页
  • 作者单位

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Division of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School Boston, MA 02115, USA;

    Dr.Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    The State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Shanghai 200031,China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Division of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School Boston, MA 02115, USA;

    The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    The State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Shanghai 200031,China;

    Institute of Cell Biology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Dr.Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University, Hangzhou, Zhejiang 310058, China;

    Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058,China;

    The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health,Boston, MA 02115, USA;

    Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058,China;

    Division of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School Boston, MA 02115, USA;

    The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Division of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School Boston, MA 02115, USA;

    Dr.Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health,Boston, MA 02115, USA;

    Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Stem Cell Institute, Zhejiang University, Hangzhou, Zhejiang 310058,China;

    The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Department of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China;

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health,Boston, MA 02115, USA;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:01:42
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号